Results 71 to 80 of about 5,658 (197)
Effect of cln3 knockout on cell proliferation and pinocytosis.
(A) Axenic growth of AX3 cln3−, cln3−/[act15]:Cln3:GFP, and AX3/[act15]:Cln3:GFP cells in HL5 medium. Data presented as mean concentration (×106 cells/ml) ± s.e.m (n = 10–20). (B) Axenic growth of AX3 and cln3− cells in FM medium.
Robert J. Huber (646534) +2 more
core +1 more source
Cln3 interacts with Cdc4 and Grr1.
(A) Cln3 interacts with Cdc4 and Grr1. Myc and GST Western blots showing pull-downs of GST, GST-Cdc4ΔF and GST-Grr1ΔF proteins from grr1Δ cdc4-1 cells expressing Cln3-13Myc (wt) or Cln3 truncation mutants (described in Figure S2B).
Benjamin D. Landry (149420) +3 more
core +1 more source
CLN3 deficiency leads to neurological and metabolic perturbations during early development
Cln3 CRISPR mutant zebrafish larvae display BMP depletion and accumulation of glycerophosphodiesters and cholesteryl esters at very early developmental stages, recapitulating key features of human CLN3 disease. Juvenile neuronal ceroid lipofuscinosis (or
Ursula Heins-Marroquin +17 more
doaj +1 more source
Wolfram syndrome (WFS) is a progressive neurodegenerative disease characterized by diabetes insipidus, diabetes mellitus, optic atrophy, and deafness. WFS1 and WFS2 are caused by recessive mutations in the genes Wolfram Syndrome 1 (WFS1) and CDGSH iron ...
Melanie A. Jones +12 more
doaj +1 more source
F-box protein specificity for g1 cyclins is dictated by subcellular localization. [PDF]
Levels of G1 cyclins fluctuate in response to environmental cues and couple mitotic signaling to cell cycle entry. The G1 cyclin Cln3 is a key regulator of cell size and cell cycle entry in budding yeast.
Benjamin D Landry +3 more
doaj +1 more source
The neuronal ceroid lipofuscinoses (NCLs) are the most common neurodegenerative disorders of childhood. We have examined mRNA levels of the CLN1, CLN2, and CLN3 genes, which are associated with the infantile, late infantile, and juvenile forms of NCL in 64 different human tissues, and have grouped the results into gastrointestinal tract, central ...
S, Chattopadhyay, D A, Pearce
openaire +2 more sources
The Case for Master Protocols for Rare Neurological Diseases
Master protocol trials allow for simultaneous multiple hypothesis testing within a common framework and might be applicable for rare diseases. In May 2025, the Network for Excellence in Neuroscience Clinical Trials convened a multistakeholder conference to discuss master protocol trials in rare neurological disorders.
Jennifer Vermilion +8 more
wiley +1 more source
Juvenile neuronal ceroid lipofuscinosis (JNCL) or Batten disease is an autosomal recessive neurodegenerative disorder of children caused by mutation in CLN3.
Song-Lin Ding +3 more
doaj +1 more source
The c.1A > C start codon mutation in CLN3 is associated with a protracted disease course
Background CLN3 disease is a disorder of lysosomal homeostasis predominantly affecting the retina and the brain. The severity of the underlying mutations in CLN3 particularly determines onset and course of neurological deterioration.
Willemijn F. E. Kuper +7 more
doaj +1 more source
Identification and morpholino targeting of the zebrafish Cln3 gene.
(A) CLUSTAL alignment indicates that zebrafish Cln3 amino acid sequence (second row) is 62% similar and 49% identical to human CLN3 (first row). Black background indicates identical residues shared between human and zebrafish, grey background indicates ...
Jonathan D. Cooper (169584) +5 more
core +1 more source

